Progress in Mind United Kingdom | Progress In Mind

Home

Alzheimer's Disease

Congress highlights

It’s in the blood – identification of plasma biomarkers brings hope for screening and early detection of Alzheimer’s disease

The recent discovery and validation of blood biomarkers offers huge potential for the early...

Alzheimer's Disease, Parkinson's Disease

Congress highlights

Gut bacteria may trigger Alzheimer’s disease

The role of the gut and its microbiota in neurodegenerative diseases has gained a lot of attention...

Depression, Schizophrenia

Stigma – time to change attitudes

Stigma. During a symposium at this year’s EPA, four specialists advocated various approaches...

Alzheimer's Disease

Congress highlights

Why do star cells damage neurons in neurodegenerative diseases? New insights into Alzheimer’s disease pathogenesis

Why do star cells damage neurons in neurodegenerative diseases, including Alzheimer’s disease...

Alzheimer's Disease

Congress highlights

Is it time to test anti-tau interventions in patients with asymptomatic Alzheimer’s disease?

The microtubule-associated protein tau is a major component of the neurofibrillary tangles (NFT) of...

Congress highlights

Fit for life: Environmental risk factors and schizophrenia

Risk and resilience to mental disorders have been investigated in terms of both environmental and...

Parkinson's Disease

Congress highlights

Synucleinopathies see advances in biomarkers and imaging

At the 2019 Alzheimer’s and Parkinson’s Diseases Congress (ADPD) in Lisbon, researchers...

Congress highlights

Early dialogues with patients are informing medicines development

A 200-strong audience of health economics and outcomes research professionals at ISPOR 2018...

What do patients want and expect from their treatment for depression?

How aligned are treatment expectations between clinicians and patients? Even in the era of...

Is GDPR a threat or an opportunity?

Digital patient data can facilitate treatment personalisation and improvements in the quality and...

Congress highlights

Functional recovery in depression: Are we doing the right thing for the treatment of depression?

Major depressive disorder (MDD) is a heterogeneous disease characterized by many different mood,...

Congress highlights

From probiotics to psychobiotics: Nutrition, gut and brain

The weight of microbes in our gut is about the same as the weight of our brain.1 Almost certainly...

Country selection

We are registering that you are located in Brazil - if that's correct then please continue to Progress in Mind Brazil

Not located in Brazil?
Go to a different regional HUB

Continue to Progress in Mind Continue to Progress in Mind Brazil Continue to Progress in Mind MENA Continue to Progress in Mind Spain Continue to Progress in Mind Italy Continue to Progress in Mind South East Asia Continue to Progress in Mind South Africa Continue to Progress in Mind United Kingdom Continue to Progress in Mind Sweden Continue to Progress in Mind Norge Continue to Progress in Mind Denmark Continue to Progress in Mind Finland Continue to Progress in Mind Japan Continue to Progress in Mind България Continue to Progress in Mind Israel

By clicking on this link, you are now leaving UK Progress in Mind Resource Center website. Lundbeck UK Ltd. Is not responsible for the content on this external website.

Continue to

Cancel

You are leaving

Progress in Mind United Kingdom
HCP Access verification required

To gain access, please provide details to verify you are a healthcare professional.

If you are not located in the United Kingdom click here.

Already registered Register

Login as a registered health care professional

Please enter your email to continue

Register as a health care professional

Please enter your email to continue

Hello
Please confirm your email

We have just sent you an email, with a confirmation link.
Before you can gain full access - you need to confirm your email.

The website is created by Lundbeck UK for UK healthcare professionals only.

Accept

Decline